Philadelphia Style Features Brandi Gregge as an Aesthetics Innovator
Philadelphia Style Magazine featured Mint & Needle Founder and Aesthetic Injector Brandi Gregge in its "Innovators in Aesthetics & Beauty."
Brandi Gregge founded Mint & Needle in 2019 in order to provide a place where people could find their confidence. Gregge works and trains with the top aesthetic medicine companies in the world and is constantly adding the newest technology to her medical aesthetic boutique. “My mission is not to change my patient’s looks, but to enhance their natural features.” She does this through a variety of aesthetic treatments, all using medical-grade products and services.
The most common treatments are non-surgical aesthetic medical treatments like Botox/Xeomin, Radiofrequency Microneedling and Cool Peel as well as Biostimulator treatments like Hyper Dilute Radiesse or Sculptra. Medical grade skincare products are also on the rise, which are science-backed and contain the purest ingredients compared to over the counter. But above all, Gregge and her team at Mint & Needle work hard to give their patients a natural look through the use of these innovative products and services. “A common misconception is that you’ll look unnatural after an aesthetic medical procedure. The truth is, if you are in the hands of a high-quality provider, you will always look naturally your best.”
Gregge believes that aesthetics medicine is a form of art and having an eye for it is crucial when assessing and enhancing one’s natural beauty. “Our industry is ever-changing and it is our responsibility to stay abreast with the most effective and safe treatments and products.”
“Aesthetic medicine not only impacts your outward appearance, it transforms how you feel inward about yourself. When we look our best, we feel our best, which empowers us to go out into the world presenting our best self! It truly isn’t about how others see us, but how we see ourselves—and aesthetic medicine adds a special, and natural, pep in our step.” (Philadelphia Style, 2023)
